Clinical Trial

The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA)

Study acronym: STEVIA
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a multicenter open-label, single-arm, dose escalation phase I clinical trial to evaluate the safety and tolerability of SNE-101 in patients with acute ischemic stroke
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-21; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2026-07-01
Trial Details
NCT Number NCT06995625
Lead Sponsor S&Ebio Co. Ltd.
Conditions Acute Ischemic Stroke AIS
Enrollment 18 participants
Start Date 2026-06-22
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-06